Lead Opinion
ORIGINAL PROCEEDING OF PROHIBITION
Relators, comprised of Wyeth and various other pharmaceutical companies, seek a writ of prohibition to prevent the trial court from denying their motions to dismiss claims pending against them on forum non conveniens grounds. Specifically, they claim that the trial court abused its discretion in denying their motions to dismiss because all the relevant factors in the forum non conveniens analysis favor dismissal. While many of the relevant factors weigh in favor of applying the doctrine of forum non conveniens, not all weigh in their favor. In particular, the pharmaceutical companies fail to show that other courts are available to the plaintiffs and that trying the cases in Missouri would be oppressive to the pharmaceutical companies or impose an undue burden on Missouri courts. This Court’s preliminary writ of prohibition is quashed.
Factual and Procedural Background
Plaintiffs filed suit on July 7, 2004, in the Circuit Court of the City of St. Louis for injuries allegedly caused by their ingestion of prescription hormone therapy drugs manufactured by Wyeth and other pharmaceutical companies. The original petition was filed on behalf of 186 plaintiffs, who were women who had taken the drugs and their husbands or representatives of the estates of deceased hormone therapy users. Twenty-one of the original plaintiffs were Missouri residents. There were 34 defendants, who were manufacturers of the hormone therapy drugs and pharmacies that allegedly sold the drugs. The case was removed to federal court but then remanded to the state trial court. At the request of the pharmaceutical companies, the trial court subsequently severed the claims of the individual plaintiffs and, in response to the pharmaceutical companies’ motion to dismiss, granted plaintiffs leave to file amended complaints. One of the grounds in the motion to dismiss was the doctrine of forum non conveniens, which the trial court overruled. The pharmaceutical companies then removed the majority of the cases, including the cases of all Missouri-resident plaintiffs, to federal court in Arkansas.
The pharmaceutical companies then filed motions to dismiss ten of the remaining claims on forum non conveniens grounds. In support of their motions, the companies attached exhibits. No hearing was held on the motions. On November 2, 2006, in ten separate orders, the trial court overruled the companies’ motions to dismiss. In its order in each case, the trial court listed the considerations to weigh in the forum non conveniens analysis and then wrote:
Here, the Court notes that this action has been pending for over two years and that substantial discovery has already been performed. The lawsuit was originally filed on July 7, 2004 and joined the claims of multiple plaintiffs, all of whom*219 claimed they were injured as a result of taking hormone therapy drugs. The ease was then removed to federal court and subsequently remanded back to this Court. On August 24, 2005, the Court ordered the cases severed. Pursuant to the Court’s ruling, a new Amended Complaint was filed on behalf of each of the individual plaintiffs.
The Court further notes that Defendants do a substantial amount of business within the State of Missouri, marketing and distributing their products to Missouri residents. The Court also does not believe an undue burden on this Circuit will be created by the prosecution of this case in the City of St. Louis.
Considering all of these matters together with the knowledge that the doctrine of forum non conveniens is to be applied with caution and only upon a clear showing of inconvenience and when the ends of justice require it, the Court finds that Defendants’ Motion to Dismiss Based on Forum Non Conveniens should be overruled.
The pharmaceutical companies claim that they are entitled to an order prohibiting the trial court from taking any further action in these cases, other than dismissing the cases on forum non conveniens grounds, because the trial court abused its discretion in overruling their motions to dismiss. Specifically, the companies assert that all the factors relevant to determining whether a forum is inconvenient weigh heavily in their favor.
Standard of Review
Because the question of whether to dismiss a case for inconvenient forum requires the court to weigh multiple factors the decision is left largely to the trial court’s discretion. Besse v. Missouri Pacific R. Co.,
Writ of Prohibition is an Appropriate Remedy
“Prohibition is a discretionary writ, and there is no right to have the writ issued.” State ex rel. Linthicum v. Calvin,
The Forum Non Conveniens Doctrine
Although a plaintiff has the right to choose any forum where there is proper
In State ex rel. Chicago, R.I. & P.R. Co. v. Riederer, this Court listed six important, but non-exclusive, factors for the trial court to weigh in determining whether a suit should be dismissed on the grounds of inconvenient forum.
In addition to analyzing whether the six factors listed above weigh heavily in the companies’ favor, it is also necessary to determine whether permitting the trial to proceed in Missouri would cause an injustice due to oppression of the defendant or undue burden on the court. Plaintiffs assert that this consideration is a second prong in the analysis that the companies fail to satisfy. The impression that the forum non conveniens analysis includes a second prong appears to be the result of the following passage from this Court’s opinion in Anglim:
In the context of an appeal from an order overruling a motion to dismiss based on a claim of inconvenient forum, the decision of the trial court is not to be disturbed unless the appellate court is firmly convinced of two propositions. First, the appellate court must be convinced that the relevant factors weigh heavily in favor of applying the doctrine of forum non conveniens. Second, the court must be convinced that permitting the case to be tried in Missouri would lead to an injustice because such trial would be oppressive to the defendant or impose an undue burden on Missouri courts.
The analysis is the same whether Anglim creates a “second prong” to the forum non conveniens analysis or is, instead, simply the recognition that there are two primary considerations in the forum non conveniens analysis. In determining whether the forum is inconvenient, courts shall consider both the private interests of the litigants and the public interest factors. Gulf Oil Corp.,
Applying the first factor to the facts of the cases here, none of the plaintiffs’ causes of action accrued in Missouri. The women were prescribed hormone therapy, purchased and ingested the drugs, and were injured in northeastern states, not Missouri. Further, in most of the cases, the medications were ingested in the plaintiffs’ home states. This factor weighs in favor of dismissal.
The second Riederer factor is the location of witnesses. Here, it is undisputed that no potential witnesses are located in Missouri and that the witnesses would be outside the circuit court’s subpoena power. The significance of this fact in assessing the inconvenience of trial in Missouri is not shown, however, because the pharmaceutical companies do not identify any actual witness, the location of any witness, or even the number of witnesses anticipated. Instead, the companies simply assert that all doctors, nurses, family, friends, coworkers, and other observers live in each plaintiffs home state. Beyond the general allegations regarding plaintiffs’ witnesses, the pharmaceutical companies did not provide the identity or location of any defense witness. “On this, as on other factual matters, the moving party has the initial burden of establishing the relative inconvenience caused by the witnesses’ location.” Id. at 304. While some inconvenience is apparent from non-resident witnesses, the pharmaceutical companies did not provide the trial court with sufficient evidence to quantify that inconvenience.
The third factor is residence of the parties. It is undisputed that no party in these suits is a Missouri resident. All the plaintiffs are residents of one of four northeastern states: Delaware, New Jersey, New York, and Pennsylvania. None of the defendant pharmaceutical companies is incorporated or headquartered in Missouri. All but two of the pharmaceutical companies are Delaware corporations; Qualitest Pharmaceuticals, Inc., is an Alabama corporation, and Solvay Pharmaceuticals, Inc., is a Georgia corporation. Four of the corporate headquarters are located in New York, two in Michigan, one in Alabama, one in Delaware, one in Georgia, one in New Jersey, and one in Pennsylvania. Again, while some inconvenience is apparent, these facts are insufficient to quantify the inconvenience to the companies caused by plaintiffs’ and defendants’ nonresidence. “A corporation may be created under the laws of one state, have its headquarters in another state, and do its primary business in yet one or more other states.” Id.
The fourth factor is whether there is any nexus between the lawsuit and the place suit is brought. Here, there is no apparent nexus between these particular cases and Missouri. There is a nexus between the pharmaceutical companies and Missouri, however. All of the companies do a substantial amount of business in Missouri, marketing and distributing their products to Missouri residents. The companies operate all over the country with different states of incorporation and headquarters. Although the companies argue that a trial in St. Louis “would require everyone to travel great distances and incur the expenses associated with an out-of-town trial,” it is likely that any forum available would be equally inconvenient to the companies. The forums where the plaintiffs are residents are not necessarily forums where the companies are residents, so there still would be a need for travel and the resulting expenses. As such, the weight of this factor in determining whether trial in Missouri would be oppressive to
The fifth Riederer factor is the public factor of convenience to and burden on the court. The defendant pharmaceutical companies argue that these are complex cases that would take two to four weeks to try and would involve the application of the laws of other states. They further argue that, in 1998-2003, the 22nd Circuit ranked at the top of the circuits in numbers of complex civil cases filed per judge, total number of jury trials and highest number of jury-trial days. The trial court, however, specifically found that prosecution of the cases in St. Louis City would not overburden the court. “[T]he trial court may take notice of the congestion of its own docket.” Anglim,
Finally, with respect to the sixth factor — the availability of another court with jurisdiction affording a forum for a plaintiffs remedy — the defendant pharmaceutical companies assert that the “courts of plaintiffs’ home state[s] are perfectly capable of handling plaintiffs’ product liability claims.” They point to other hormone therapy cases pending in the plaintiffs’ home states that are subject to “coordinated proceedings” as grounds for finding that there is another court with jurisdiction available. Such general assertions are not sufficient. Whether another forum was initially available where plaintiffs could have filed their original claims is not what the sixth factor concerns. The issue to be considered by the trial court is whether each plaintiff would have a forum available, at this time, where he or she could proceed with the lawsuits in the event the current suits are dismissed. Only in this Court, in response to plaintiffs’ claim that there may be bars to them filing suit in other states, such as statutes of limitation, do the pharmaceutical companies offer to waive assertion of a statute of limitations defense for the period each case was pending in Missouri.
The defendant companies argue that if these suits are permitted to proceed because the companies do some business in Missouri, it would open Pandora’s Box, allowing any plaintiff to sue any company that does business in Missouri to the detriment of Missouri’s court system and its jurors. Plaintiffs argue that the court’s jurisdiction over their suits is not oppressive to the pharmaceutical companies and does not impose an undue burden on the court and, therefore, Missouri is not an inconvenient forum. This Court agrees that the companies have not shown that the trial court abused its discretion in overruling their motions to dismiss on grounds of forum non conveniens.
Plaintiffs’ original petition filed in the trial court included 186 plaintiffs, 21 of whom were Missouri residents. The petition, as initially filed, would have withstood a forum non conveniens challenge because of the Missouri plaintiffs. During the years since the case was filed, the pharmaceutical companies removed the entire case to federal court, which later remanded it. The companies then obtained the severance of the plaintiffs’ claims and chose to remove all but eleven plaintiffs to federal court on diversity grounds. Only then were the remaining plaintiffs vulnerable to a forum non conveniens challenge.
The defendant pharmaceutical companies have the potential for gaining additional advantages, beyond having a more convenient forum, if their renewed motions to dismiss for forum non conveniens are
In analyzing the relevant factors, the defendant pharmaceutical companies argue that Missouri is an inconvenient forum, primarily because plaintiffs’ witnesses do not reside in Missouri and the parties would have to travel great distances and incur expenses. In so arguing, the companies have not presented factual information about the nature of that inconvenience. And, as noted earlier, the companies failed to prove that it is of great inconvenience or burden on them to try the cases in Missouri because there was a lack of evidence as to where the companies have their principal places of business, the evidence showed that the companies are headquartered in many different states, and, if plaintiffs’ suits are dismissed, the companies would be required to try the cases in the multiple states where the plaintiffs reside. The defendant pharmaceutical companies have not shown that the plaintiffs’ filing and maintenance of the suits in Missouri was for the purpose of vexing, oppressing or harassing the companies, which the doctrine of forum non conveniens is intended to prevent. An-glim,
Conclusion
Under the special facts of this case, the trial court did not abuse its discretion in fading to dismiss the lawsuits on the grounds that Missouri is an inconvenient forum. The relevant forum non conve-niens factors do not weigh heavily in favor of dismissal, and the defendant pharmaceutical companies fad to show that permitting the cases to be tried in Missouri would lead to an injustice because the trials would be oppressive to defendants or would impose an undue burden on Missouri courts. The trial court, therefore, did not abuse its discretion in fading to dismiss the lawsuits on the grounds that Missouri is an inconvenient forum. This Court’s preliminary writ is quashed.
Notes
. Federal hormone therapy cases are consolidated in a multidistrict litigation proceeding in the United States District Court for the Eastern District of Arkansas. See In re Prempro Products Liability Litigation,
Concurrence Opinion
concurring.
After deliberation of the facts and consideration of long established legal precedent, this Court holds that the preliminary writ of prohibition issued for reasons of forum non conveniens should be and is hereby quashed. Therefore, the circuit court of the City of St. Louis may proceed to adjudicate these cases.
The saga of hormone replacement therapy litigation continues. A multitude of cases were filed in the St. Louis City Circuit Court against national pharmaceutical companies in July, 2006. Chapter Two opened with the defendant companies seeking removal to federal court from the St. Louis City Circuit Court.
Ad but eleven of these cases involving hormone replacement therapy were rerouted to the multi-district litigation in Arkansas, thereby ending Chapter Two.
As Chapter Four opened, the defendants requested the Hon. Thomas C. Grady, presiding judge of the St. Louis City Circuit Court, to exercise his discretion and decline jurisdiction in ten of the hormone replacement therapy cases on the basis of forum non conveniens.
FACTUAL AND PROCEDURAL BACKGROUND
In forum non conveniens, the trial judge has personal and subject matter jurisdiction, which in layman terms means that the trial court has the legal authority to proceed. Anglim succinctly defined forum non conveniens:
The doctrine oí forum non conveniens provides that notwithstanding proper jurisdiction and venue by letter of the statute, a trial judge has discretion to not exercise jurisdiction if the forum is seriously inconvenient for the trial of the action involved and if a more appropriate forum is available to the plaintiff.2
Thus, the doctrine of forum non conve-niens grants the trial judge the discretion to examine the facts of the case and to decline to proceed “if the forum is seriously inconvenient ... and if a more appropriate forum is available to the plaintiff.”
But a plaintiffs choice of forum is not to be disturbed except for “weighty reasons” and the case should be dismissed only the “balance is strongly in favor” of the defendant.4
Judge Grady did so, examined the ten cases, considered the facts and the law, then issued ten separate but explanatory orders telling why the trial court would not exercise its discretion to dismiss these cases. Instead, the court would do its duty and continue to adjudicate the hormone replacement therapy cases.
In Chapter Five, the defendants challenged Judge Grady’s considered opinions and requested that the Missouri Court of Appeals, Eastern District, prohibit Judge Grady from proceeding with these cases, based upon forum non conveniens considerations.
A preliminary writ was issued, but after consideration, that court quashed its writ, thereby allowing Judge Grady to adjudicate these cases in Chapter Six.
WRIT OF PROHIBITION vs. TRIAL COURT DISCRETION
But defendants continue their authorship of this saga in Chapter Six, this time requesting that this Court prohibit Judge Grady from proceeding based upon forum non conveniens considerations. By this decision, this Court must address and de
Despite its long-standing history of respecting discretionary orders of forum non conveniens motions by trial judges, this Court, a court of review and a court of error, is requested to embark on an early course of active involvement in forum non conveniens litigation that most certainly invites more writ filings and usurps trial court discretion and case management.
RIEDERER FACTORS APPLICABLE TO FORUM NON CONVENIENS
These issues, trial court discretion and this Court’s interlocutory application of forum non conveniens, are intertwined. Traditionally, the judicial system allows the plaintiff to select the forum by filing suit.
(1) place of accrual of the cause of action,
(2) location of witnesses,
(3) the residence of the parties,
(4) any nexus with the place of suit,
(5) the public factor of the convenience to and burden upon the court, and
(6) the availability to plaintiff of another court with jurisdiction of the cause of action affording a forum for plaintiffs remedy.9
But, first consider the reverence with which past appellate courts have respected trial court discretion in deciding forum non conveniens issues.
Besse emphatically held that “our writs are issued grudgingly, and not to correct discretionary rulings,”
Thus, against this long history of supporting trial court discretion on forum non conveniens cases, in order to support the issuance of this extraordinary writ of pro
Continuing, this Court must also evaluate Judge Grady’s ruling against those legal standards that govern forum non conveniens decisions. In Holliger, this Court ruled,
[Djenial of a motion to dismiss on the grounds of forum non conveniens should not be disturbed unless the relevant factors weigh heavily in favor of applying the doctrine and litigating the case in Missouri would lead to an injustice because such trial would be oppressive to the defendant or would impose undue burden on the Missouri courts.16
Since forum non conveniens decisions are “fact intensive” and the weight to be afforded any factor is dependent on the circumstances,
Of greatest moment in this inquiry is the “nexus” factor. Webster’s unabridged dictionary has multiple definitions, to-wit; connection or interconnection; tie; link or a connected group or series.
Therefore, the logical question is simply whether there is a “nexus” connection between Missouri
To prevail on a claim that the trial court abused discretion finding the defendant has a Missouri ... nexus, the defendant must produce substantial evidence clearly demonstrating that the corporate business activities in Missouri are limited or that those activities have no significant relationship to the jurisdiction in which the case is filed.21
The record is lacking on any limitation of business activities in Missouri and, to the contrary, shows a significant relationship with Missouri citizens. Defendants have targeted Missouri citizens for business, clinical studies and profit, but shun Missouri justice. If the safety, well being and future health of Missouri citizens is not a Missouri interest that merits judicial protection and Missouri adjudication, then what does? Must a Missouri citizen be harmed before Missouri judicial interest attaches? This author believes otherwise.
Defendants have a thriving pharmaceutical business in Missouri with resident and non-resident representatives. These contacts or incidents establishing personal ju
The duty of establishing/ontm non con-veniens lies with the defendants.
The statistics
In short, as with the nexus factor, defendants fail to establish that the judicial burdens on the St. Louis City Circuit Court mandate imposition of forum non conveniens.
Factor Two, the location of witnesses, strives to provide live testimony by eyewitnesses and treating physicians with a local forum. Defendants here contend that the live testimony of plaintiffs’ prescribing and treating physicians at trial is imperative. In the real world of 2007 America, videotape testimony by expert witnesses, especially physicians, is more common place than live testimony.
Besse targeted eyewitnesses and treating physicians for live testimony by providing a convenient local forum, but expressly acknowledged that “doctors often testify by Reposition, even in trials in their home area.”
Finally, defendants imply there are equally available forums for hormone replacement therapy trials, suggesting that affirmative defenses in other forums can be waived and trials fairly conducted. Interestingly, in addressing the “witness” availability factor, defendants were both untrusting and skeptical of St. Louis City Circuit Court’s limited subpoena power “to compel” testimony by non-resident witnesses, but entreat this Court “to trust” foreign tribunals to waive affirmative defenses in the interest of justice.
Again, there was no information, data or commitment by any party or foreign tribunal that these hormone replacement therapy cases will receive a fair and just adjudication elsewhere — only statements by counsel. In the absence of that assurance, caution must prevail, and this Court must resolve Factor Six with certainty — that being Missouri justice.
Evaluation of the justice prong necessarily includes consideration of the impartiality and fairness of the St. Louis city jurors. Already Judge Wolff has established their dedication to duty and willingness to serve.
Again, Judge Grady expressly decreed that these ten cases would not burden the St. Louis City Circuit Courts. Additionally, defendants have established thriving businesses in Missouri. In Holliger,
Finally, in August 1999, the Missouri Court of Appeals, Western District, declared in Mauer “that no Missouri appellate court has ever issued a writ directing a trial court to dismiss a case on grounds of forum non conveniens”
I respectfully concur in quashing the preliminary writ, believing that Judge Grady’s denial of forum, non conveniens dismissal was factually and legally correct and, furthermore, that the denial was discretionary within his jurisdiction and deserving of this Court’s affirmation.
. One case remained with the St. Louis City Circuit Court.
. Anglim v. Missouri Pacific R.R. Co.,
. Anglim,
. Anglim,
. These orders are published in the Index portion of the appellate court filing.
. Mauer,
. Besse v. Missouri Pacific R.R. Co.,
. State ex. rel. Chicago, Rock Island & Pacific R.R. Co. v. Riederer,
. Riederer,
. See Anglim,
. Anglim,
. Besse,
. Id. at 743; State ex rel. McCulloch v. Schiff,
. Holliger,
. Holliger,
. Id. at 302-03; Mauer,
. Westbrooke,
. Webster's new international Dictionary 1649 (2d ed. 1950).
. Anglim,
. Mauer,
. Anglim,
. Anglim,
. See also, Anglim,
. State ex rel. Linthicum v. Calvin, 57 S.W.3d 855, 860 (Mo. banc 2001). Interestingly, the St. Louis City Circuit Court was credited with 506 jury trials consuming 1388 days for fiscal year 2000. Assuming twelve person juries, 506 juries required only 6,072 jurors to hear and decide the cases. The average jury trial took 2.74 days or less than 3 trial days. Certainly, that constitutes dedicated service, but that data hardly establishes an “overburdened” status, considering the population of the City of St. Louis was 348,189 (actual) according to the 2000 U.S. Census, www. factfinder.census.gov, U.S. Census Bureau-American FactFinder Portion. If so, the percentage of citizen involvement was less than 2% annually. Noteworthy, the City of St. Louis population remains stable, the 2004 estimate being 332,662 and the 2007 estimate being 350,759.
. Anglim,
.This judge has examined exhibit 30, the January 2004, Report of the Joint Interim Committee on Judicial Resources in Missouri. The exhibit consisting of two face pages, the Table of Contents, page four signature page for members of the Joint Interim Committee on Judicial Resources in Missouri and only three pages of data, i.e., pages 45, 47 and 49, from a 57-page report detailing the allocation of Missouri judicial resources. Page 45 compared the 45 judicial circuits for fiscal year 2003 for "Average Filing per Judge.” The caseload analysis was divided into nine distinct categories and an overall category. The St. Louis City Circuit Court ranked 30th in the overall category of average filings per judge, but first in "Complex CCV” cases and second in "Circuit Civil” cases. The St. Louis City Circuit Court ranked 29, 12, 27, 32, 45, 26 and 3 in other categories. Notably, the 16th Circuit ranked 7th overall, and 3, 9, 1, 2, 15, 21, 42, 25 and 12. Similarly, the 31st Circuit was 1st in overall filings and 2, 5, 5, 4, 6, 13, 1, 23 and 19 in individual categories— certainly emblematic of great service. Likewise, the 19th Circuit, which was first in the "Circuit Civil” category and 13th overall, provided great service. The 23rd Circuit was 4th overall, and the 29th Circuit was 2nd overall. Page 47 listed each circuit’s number of jury trials for fiscal years 1998 through 2003, and page 49 listed each circuit's number of jury
. Anglim,
. Anglim,
. Being a trial judge for almost 21 years, this jurist’s experience is that live testimony of physicians is a pipedream and nostalgic memory.
. Besse,
. Anglim,
. Taylor,
. Calvin,
. Holliger,
. Westbrooke,
. Mauer,
. Id.
. Mauer,
. Anglim,
